Soleno Therapeutics is a public, clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare diseases.

Geron is a public, late-stage clinical biopharmaceutical company focused on the development and potential commercialization of a first-in-class telomerase inhibitor, imetelstat, in hematologic myeloid malignancies.

Executive Vice President and member of the core executive team reporting to the CEO of Reata Pharmaceuticals for over 7 years through the company’s $7.3B acquisition by Biogen in September 2023. Reata successfully developed small molecule therapeutics for the treatment of rare and devastating diseases. Dawn was part of a small executive team responsible for early strategic portfolio decisions, clinical trial design and multiple corporate financing efforts, helping to resource development-stage assets. She has broad operational experience, establishing the teams and infrastructure supporting organizational growth from 30 employees to over 300. She served as a member of the joint steering committee governing the company’s corporate international partnership with Japanese development partner, Kiowa-Kirin Corporation. Through her leadership, the strategic and operational plans for the company’s first product launch in the US and globally were developed. She prepared the company for approval, and successfully executed launch and commercialization in 2023.

Vice President Sales, US • Commercial Leadership of Hematology/Oncology organization responsible for IMBRUVICA revenue.o Organization Build: Lead the efforts to establish all needed operations and infrastructure to support commercialization of first product (hematology). • History-Making Hematology Launch: Second commercial year exceeded revenue expectations, generating over $1B in sales (US sales)Company was acquired by AbbVie for $21B in 2015.

SKY Pharmaceuticals & Rx Pak September 2011 to March 2013• National responsibility for 2 companies and revenue centers. Leadership of multiple teams including sales, marketing, contract management, project management and customer service, driving acute care hospital sales.• Profitability and margin management of entire product portfolio (P&L).• Responsible for financial expectations across all revenue centers and managing OPEX to within 3% of plan.• Team and organizational development. Sales force alignment and sizing, compensation plan development.• Lead sales strategy across multiple customer segments including acute care, wholesalers, GPO’s & federal.• Business Development: Acquisition and divestiture.

Area Manager, Central, US • Therapeutic areas include oncology and hematology, immunology, dermatology• Buy and bill sales model• Built and developed 2 sales teams that consistently lead the nation in performance.• Division of the Year in and 2008 and 2010• Sr. Operations Director, July-December 2008

Vice President, Sales & Operations, Northeast Lead Hospital Acute Care/Medical-Surgical sales force and operations across 7 state region in the northeast. 3 Distribution centers, Sales Management and Sales support teams.

Therapeutic area experience includes Oncology, Dermatology, Cardiovascular, Neuroscience, Metabolic and Anti-infective.